CADASIL: A short review of the literature and a description of the first family from Greece

Functional Neurology

Volumn 21, Issue 2, 2006, Pages 77-82

  Vikelis, Michail ^a,c   Xifaras, Michail ^b   Mitsikostas, Dimos Dimitrios ^a  

^a ATHENS NAVAL HOSPITAL   (Greece)

^b Renal Unit   (Greece)

^c NONE   (Greece)

Author keywords

Autosomal dominant arteriopathy; CADASIL; Notch3 gene; Subcortical dementia

Indexed keywords

ACETYLSALICYLIC ACID; BENZODIAZEPINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; BRAIN ISCHEMIA; CADASIL; CASE REPORT; CLINICAL FEATURE; DEMENTIA; FAMILIAL DISEASE; FEMALE; GENETIC ANALYSIS; GENETIC DISORDER; GREECE; HUMAN; LITERATURE; MALE; MIGRAINE; MOOD DISORDER; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIODIAGNOSIS; SHORT SURVEY;

CADASIL; DIAGNOSIS, DIFFERENTIAL; FEMALE; GREECE; HISTORY, 20TH CENTURY; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PEDIGREE;

EID: 33747286430     PISSN: 03935264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (30)

1. Joutel A, Corpechot C, Ducros A et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 1996;383:707-710
2. Desmond D, Moroney J, Lynch T, Chan S, Chin S, Mohr JP. The natural history of CADASIL. Stroke 1999;30:1230-1233
3. Markus HS, Martin RJ, Simpson MA et al. Diagnostic strategies in CADASIL. Neurology 2002;59:1134-1138
4. Dichgans M, Mayer M, Uttner I et al. The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol 1998;44:731-739
5. Vahedi K, Chabriat H, Levy C, Joutel A, Tournier-Lasserve E, Bousser MG. Migraine with aura and brain magnetic resonance imaging abnormalities in patients with CADASIL. Arch Neurol 2004;61:1237-1240
6. Ravaglia S, Costa A, Santorelli FM, Nappi G, Moglia A. Retinal migraine as unusual feature of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Cephalalgia 2004;24:74-77
7. Buffon F, Porcher R, Hernandez K et al. Cognitive profile in CADASIL. J Neurol Neurosurg Psychiatry 2006;77:175-180
8. Fattapposta F, Restuccia R, Pirro C et al. Early diagnosis in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL): the role of MRI. Funct Neurol 2004;19:239-242
9. O'Sullivan M, Jarosz J, Martin RJ, Deasy N, Powell JF, Markus HS. MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. Neurology 2001;56:628-634
10. Auer D, Putz B, Gossl C, Elbel G, Gasser T, Dichgans M. Differential lesion patterns in CADASIL and sporadic subcortical arteriosclerotic encephalopathy: MR imaging study with statistical parametric group comparison. Radiology 2001;218:443-451
11. Singhal S, Rich P, Markus HS. The spatial distribution of MR imaging abnormalities in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy and their relationship to age and clinical features. Am J Neuroradiol 2005;26:2481-2487
12. Davous P, Fallet Bianco C. Familial subcortical dementia with arteriopathic leucoencephalopathy. A clinico-pathological case. Rev Neurol (Paris) 1991;147:376-384
13. Ruchoux MM, Mange CA. CADASIL: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J Neuropathol Exp Neurol 1997;56: 947-964
14. Ruchoux MM, Guerouaou D, Vandenhaute B, Pruvo JP, Vermersch P, Leys D. Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Acta Neuropathol (Berl) 1995;89:500-512
15. Ebke M, Dichgans M, Bergmann M et al. CADASIL: skin biopsy allows diagnosis in early stages. Acta Neurol Scand 1997;95:351-357
16. Mayer M, Straube A, Bruening R et al. Muscle and skin biopsies are a sensitive diagnostic tool in the diagnosis of CADASIL. J Neurol 1999;246:526-532
17. Joutel A, Vahedi K, Corpechot C et al. Strong clustering and stereotyped nature of Notch 3 mutations in CADASIL patients. Lancet 1997;350:1511-1515
18. Artavanis-Tsakonas S, Matsuno K, Fortini M. Notch signaling. Science 1995;268:225-232
19. Peters N, Opherk C, Bergmann T, Castro M, Herzog J, Dichgans M. Spectrum of mutations in biopsy-proven CADASIL: implications for diagnostic strategies. Arch Neurol 2005;62:1091-1094
20. Federico A, Bianchi S, Dotti MT. The spectrum of mutations for CADASIL diagnosis. Neurol Sci 2005;26:117-124
21. Dichgans M, Herzog J, Gasser T. NOTCH3 mutation involving three cysteine residues in a family with typical CADASIL. Neurology 2001;57:1714-1717
22. Joutel A, Chabriat H, Vahedi K et al. Splice site mutation causing a seven amino acid notch3 in-frame deletion in CADASIL. Neurology 2000;54:1874-1875
23. Singhal S, Bevan S, Barrick T, Rich P, Markus HS. The influence of genetic and cardiovascular risk factors on the CADASIL phenotype. Brain 2004;127:2031-2038
24. Gutierrez-Molina M, Caminero Rodriguez A, Martinez Garcia C, Arpa Gutierrez J, Morales Bastos C, Amer G. Small arterial granular degeneration in familial Binswanger's syndrome. Acta Neuropathol (Berl) 1994;87:98-105
25. Vahedi K, Tournier-Lasserve E, Vahedi K, Chabriat H, Bousser MG. An additional monogenic disorder that masquerades as multiple sclerosis. [letter] Am J Med Genet 1996;65:357-358
26. Williamson EE, Chukwudelunzu FE, Meschia JF, Witte RJ, Dickson DW, Cohen MD. Distinguishing primary angiitis of the central nervous system from cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: the importance of family history. Arthritis Rheum 1999;42:2243-2248
27. Hassan A, Markus HS. Genetics and ischemic stroke. Brain 2000;123:1784-1811
28. Razvi SS, Davidson R, Bone I, Muir KW. Is inadequate family history a barrier to diagnosis in CADASIL? Acta Neurol Scand 2005;112:323-326
29. Razvi SS, Davidson R, Bone I, Muir KW. The prevalence of cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) in the west of Scotland. J Neurol Neurosurg Psychiatry 2005;76: 739-741
30. Peters N, Herzog J, Opherk C, Dichgans M. A two-year clinical follow-up study in 80 CADASIL subjects. Progression patterns and implications for clinical trials. Stroke 2004; 35:1603-1608